Protection of hepatic microcirculatory disturbance due to the ischemia-reperfusion injury
对缺血再灌注损伤引起的肝脏微循环障碍的保护作用
基本信息
- 批准号:13671278
- 负责人:
- 金额:$ 2.3万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2001
- 资助国家:日本
- 起止时间:2001 至 2002
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Abstract[Background/Aim] A synthesized non-peptide endothelin receptor; SB209670 (SB) reported to inhibit vasoconstriction; however its effects on the post-ischemic liver microcirculation (PILMC) is still unclear. To clarify the effects of SB on the PILMC was the aim of this study.[Material and Methods] We analyses the effects of SB on not only PILMC, but also release of aspartate aminotransferase (AST), alanine aminotransferase (ALT), and lactate dehydrogenase (LDH) and the hepatocyte morphology after ischemia by intravital fluorescent microscopy. [Results] SB significantly inhibited the sinusoidal vasoconstriction, leukocyte sticking and restored the perfusion rate than NaCl administration in comparison with those of non-ischemic liver, 94.1%; vs. 83.8%, 1.54/acini vs. 5.12/acini and 93.3% vs. 70. 2%, respective, however, it did not the vasoconstriction and leukocyte sticking in the post-sinusoidal venule. SB also did not prevent release of liver enzyme and the increase of the vacuolated hepatocyte number. [Conclusion] SB protects the post-ischemic microcirculatory disturbance in the sinusoid, however it did not prevent ischemic reperfusion liver injury provably due to the conflictive effects in the post-sinusoidal venule.
摘要[背景/目的]人工合成的非肽内皮素受体SB209670(SB)具有抑制血管收缩的作用,但其对缺血后肝微循环(PILMC)的影响尚不清楚。[材料与方法]利用活体荧光显微镜观察Sb对PILMC的影响,以及对缺血后肝细胞谷草转氨酶(AST)、丙氨酸氨基转移酶(ALT)、乳酸脱氢酶(LDH)的释放及肝细胞形态的影响。[结果]SB明显抑制肝窦血管收缩、白细胞黏附,恢复灌注率,与非缺血组比较,分别为94.1%、83.8%、1.54个/腺泡和5.12个/腺泡、93.3%和70%。2%未见血管收缩和白细胞粘连于窦后小静脉。SB也不能阻止肝酶的释放和空泡化肝细胞数量的增加。[结论]Sb对缺血后肝窦微循环障碍有保护作用,但由于肝窦后小静脉的相互矛盾作用而不能预防缺血再灌注肝损伤。
项目成果
期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Expression of Cyclooxygenase-2 in the Subserosal Layer Correlates with Postsurgical Prognosis of Pathological Tumor Stage Carcinoma of the Gallbladder
浆膜下层环氧合酶-2 的表达与胆囊病理肿瘤期癌的术后预后相关
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:T.Todoroki
- 通讯作者:T.Todoroki
Synthesis and Properties of Poly [N-(2-hydroxyproprl)ethacrylaide] Conjugates of Superoxide Dismutase
超氧化物歧化酶聚[N-(2-羟丙基)乙基丙烯酰胺]结合物的合成及性能
- DOI:
- 发表时间:2002
- 期刊:
- 影响因子:0
- 作者:T.Todoroki
- 通讯作者:T.Todoroki
E-cadherin expression in the primary tumors and metastatic lymph nodes of poorly differentiated types of rectal cancer
- DOI:10.1007/s005950200004
- 发表时间:2002-01-01
- 期刊:
- 影响因子:2.5
- 作者:Kanazawa, N;Oda, T;Fukao, K
- 通讯作者:Fukao, K
T.Todoroki: "Synthesis and Properties Poly [N-(2-hydroxypropyl) methacrylamide] Conjugates of Superoxide Dismutase"Journal of Bioactive and Compatible Polymers. 17. 105-122 (2002)
T.Todoroki:“超氧化物歧化酶聚[N-(2-羟丙基)甲基丙烯酰胺]缀合物的合成和特性”生物活性和相容聚合物杂志。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
轟健: "消化器外科 12 消化器画像をめぐる話題"へるす出版. 6 (2002)
Ken Todoroki:“胃肠外科 12 个胃肠道图像主题”健康出版 6 (2002)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TODOROKI Takeshi其他文献
TODOROKI Takeshi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TODOROKI Takeshi', 18)}}的其他基金
Mucin glycoproteins in human gallbladder carcinoma and their biological effects on tumor invasion and metastasis capability.
人胆囊癌中的粘蛋白糖蛋白及其对肿瘤侵袭和转移能力的生物学作用。
- 批准号:
13671279 - 财政年份:2001
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The effect of TAK-O44 combined with SOD-DIVEMA on ischemia reperfusion liver injury.
TAK-O44联合SOD-DIVEMA对缺血再灌注肝损伤的影响
- 批准号:
11671208 - 财政年份:1999
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
SDUDIES OF HIGH MOLECULAR SUBSTANCE- SOD CONJUGATE ON PREVENSION OF HEPATIC ISCHEMLA-REPERFUSION INJURY AND HEPATIC MICROCIRCULATION
高分子物质-SOD结合物预防肝缺血再灌注损伤及肝微循环的研究
- 批准号:
08671410 - 财政年份:1996
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Prevention of reperfusion liver injury by SOD-(DIVEMA) conjugate
SOD-(DIVEMA) 结合物预防再灌注肝损伤
- 批准号:
06455003 - 财政年份:1994
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
相似海外基金
A novel treatment for REBOA complications: Hydrogen gas inhalation therapy to alleviate oxidative stress due to ischemia-reperfusion injury
REBOA并发症的新型治疗方法:氢气吸入疗法减轻缺血再灌注损伤引起的氧化应激
- 批准号:
23K21458 - 财政年份:2024
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development ofsynthetic heparin to protect liver graft from ischemia reperfusion injury duringtransplantation
开发合成肝素以保护移植肝免受移植过程中的缺血再灌注损伤
- 批准号:
10759102 - 财政年份:2023
- 资助金额:
$ 2.3万 - 项目类别:
The Role of Neutrophils in Ischemia/Reperfusion Injury following Acute Stroke
中性粒细胞在急性中风后缺血/再灌注损伤中的作用
- 批准号:
10606952 - 财政年份:2023
- 资助金额:
$ 2.3万 - 项目类别:
Zinc Protection Against Ischemia-Reperfusion Injury in Heart
锌可预防心脏缺血再灌注损伤
- 批准号:
10652915 - 财政年份:2023
- 资助金额:
$ 2.3万 - 项目类别:
Ischemia/Reperfusion injury and Myocardial edema
缺血/再灌注损伤和心肌水肿
- 批准号:
10718260 - 财政年份:2023
- 资助金额:
$ 2.3万 - 项目类别:
Role of Gasdermin D/E in intestinal ischemia-reperfusion injury
Gasdermin D/E 在肠缺血再灌注损伤中的作用
- 批准号:
23K15529 - 财政年份:2023
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Monocytic-MDSCs as resolution mediators of post-transplant lung ischemia-reperfusion injury
单核细胞-MDSC作为移植后肺缺血再灌注损伤的解决介质
- 批准号:
10677290 - 财政年份:2023
- 资助金额:
$ 2.3万 - 项目类别:
Role of Lipid Metabolism in Hepatic Ischemia Reperfusion Injury in Steatotic Livers
脂质代谢在脂肪肝缺血再灌注损伤中的作用
- 批准号:
10664736 - 财政年份:2023
- 资助金额:
$ 2.3万 - 项目类别:
ETS2-dependent control in cardiomyocyte ischemia/reperfusion injury
ETS2 依赖性控制心肌细胞缺血/再灌注损伤
- 批准号:
10501545 - 财政年份:2022
- 资助金额:
$ 2.3万 - 项目类别: